Crewe Advisors LLC Atai Life Sciences N.V. Transaction History
Crewe Advisors LLC
- $709 Million
- Q4 2024
A detailed history of Crewe Advisors LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Crewe Advisors LLC holds 5,540 shares of ATAI stock, worth $11,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,540
Previous 5,540
-0.0%
Holding current value
$11,024
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
104Shares Held
16.3MCall Options Held
367KPut Options Held
69.2K-
Morgan Stanley New York, NY3.33MShares$6.63 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$3.86 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$2.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$1.95 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$1.89 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $330M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...